 |
Platelet Aggregation Inhibitors
Research News and Information
Definition of 'Platelet Aggregation Inhibitors'Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. Common names: Platelet Aggregation Inhibitors; Aggregation Inhibitors, Platelet; Inhibitors, Platelet Aggregation; Blood Platelet Antiaggregants; Antiaggregants, Blood Platelet; Platelet Antiaggregants; Antiaggregants, Platelet; Blood Platelet Aggregation Inhibitors; Platelet Inhibitors; Inhibitors, Platelet |
Monday, November 23, 2009
Laser treatment of benign prostatic hyperplasia in patients on oral anticoagulant therapy: a review.
20 Dec 2009 
We assessed the therapeutic efficacy and safety of laser prostatectomy (LP) for treating benign prostatic hyperplasia (BPH) in patients on oral anticoagulation. We systematically reviewed previous reports, using the Pubmed database and ... Read more...
De novo development of moyamoya disease in an adult female. Case report.
30 Oct 2009 The origin of moyamoya disease remains unknown. The onset of the angiographically apparent changes of typical moyamoya disease occurs in childhood, but de novo development of the disease has not been confirmed angiographically. The authors report on ... Read more...
18 Oct 2009 Determining the most appropriate revascularization strategy for patients presenting with unprotected left main coronary (UPLM) disease has been a topic of great recent interest. During this current decade, there have been multiple clinical trials ... Read more...
Latest indexed articles for 'Platelet Aggregation Inhibitors'
These are the very latest articles for this heading:
- Laser treatment of benign prostatic hyperplasia in patients on oral anticoagulant therapy: a review. 20 Dec 2009
- De novo development of moyamoya disease in an adult female. Case report. 30 Oct 2009
- Revascularization for unprotected left main disease: evolution of the evidence basis to redefine treatment standards. 18 Oct 2009
- Responses to USPSTF guideline on aspirin for prevention of cardiovascular disease.
18 Oct 2009 - Responses to USPSTF guideline on aspirin for prevention of cardiovascular disease. 18 Oct 2009
- Predictive values of post-treatment adenosine diphosphate-induced aggregation and vasodilator-stimulated phosphoprotein index for stent thrombosis after acute coronary syndrome in clopidogrel-treated patients. 13 Oct 2009
- Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry). 13 Oct 2009
- Discovery of novel protease activated receptors 1 antagonists with potent antithrombotic activity in vivo. 6 Oct 2009
- Routine early angioplasty after fibrinolysis. 6 Oct 2009
- Hunting for the "sweet spot" in P2Y12 receptor blockade. 4 Oct 2009
- Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. 4 Oct 2009
- Prevention and management of stroke in very elderly patients. 29 Sep 2009
- Prasugrel pharmacokinetics and pharmacodynamics in subjects with moderate renal impairment and end-stage renal disease. 29 Sep 2009
- Pharmacokinetics and pharmacodynamics of prasugrel in subjects with moderate liver disease. 29 Sep 2009
- Lowering mortality in ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: key prehospital and emergency room treatment strategies. 29 Sep 2009
- Event-free 6 months of an octogenarian with an undeployed stent in the left main coronary trunk: efficacy of dual antiplatelet therapy. 29 Sep 2009
- Antiplatelet agents used for early intervention in acute coronary syndrome: myocardial salvage versus bleeding complications. 29 Sep 2009
- Timing of clopidogrel loading before percutaneous coronary intervention in clopidogrel-naive patients with stable or unstable angina: a comparison of two strategies. 29 Sep 2009
- Early abciximab administration before transfer for primary percutaneous coronary interventions for ST-elevation myocardial infarction reduces 1-year mortality in patients with high-risk profile. Results from EUROTRANSFER registry. 29 Sep 2009
- Design and rationale of the TRI-stent adjudication study (TRIAS) program. 29 Sep 2009
See a longer list of these articles.
Technical information about 'Platelet Aggregation Inhibitors'
Definition: Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
Registry Number: 0
Descriptor UI: D010975
Alternative terms: Platelet Aggregation Inhibitors; Aggregation Inhibitors, Platelet; Inhibitors, Platelet Aggregation; Blood Platelet Antiaggregants; Antiaggregants, Blood Platelet; Platelet Antiaggregants; Antiaggregants, Platelet; Blood Platelet Aggregation Inhibitors; Platelet Inhibitors; Inhibitors, Platelet; Antiplatelet Agents; Agents, Antiplatelet; Antiplatelet Drugs; Drugs, Antiplatelet; Platelet Antagonists; Antagonists, Platelet; Blood Platelet Antagonists; Antagonists, Blood Platelet;
Allowable Qualifiers: administration & dosage; adverse effects; analysis; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;
Tree Number: D27.505.954.502.780;
History Note: 88
Technical Notes: DF: PLATELET INHIB